EPO and neoplasm: Moreover, we show that EV-3/CRLF3 signaling mediates protection of human cells indicating that CRLF3 can be selectively targeted by Epo-like ligands to counteract neurodegenerative diseases without simultaneously promoting inappropriate erythropoiesis and tumor growth.